CAR T-cells: costs, comparisons, and commentary
Author:
Affiliation:
1. Department of Medicine, Queen’s University, Kingston, Ontario, Canada;
2. Canadian Cancer Trials Group, Kingston, Ontario, Canada;
3. Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada
Publisher
Informa UK Limited
Subject
Health Policy
Link
https://www.tandfonline.com/doi/pdf/10.1080/13696998.2019.1582059
Reference20 articles.
1. Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
2. Tragedy, Perseverance, and Chance — The Story of CAR-T Therapy
3. Tisagenlecleucel — the first approved CAR-T-cell therapy: implications for payers and policy makers
4. National Institute for Health and Care Excellence. Axicabtagene ciloleucel for treating diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma after 2 or more systemic therapies. August 2018. Available at: https://www.nice.org.uk/guidance/gid-ta10214/documents/appraisal-consultation-document [Accessed 14 November 2018].
5. ASBMT and ASH submitletter on CMS Mediasre Inpatient final rule. November 2018. Available at: https://www.asbmt.org/blogs/content-administrator/2018/11/01/asbmt-and-ash-submit-findings-on-cms-medicare-inpa [Accessed 14 November 2018].
Cited by 40 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Toward low-cost gene therapy: mRNA-based therapeutics for treatment of inherited retinal diseases;Trends in Molecular Medicine;2023-12
2. From bench to bedside: Challenges in implementing precision psychiatry;General Hospital Psychiatry;2023-11
3. Shedding light on the side effects of immunotherapies used for leukemia: an updated review of the literature;Expert Review of Anticancer Therapy;2023-10-09
4. Overcoming barriers to precision psychiatry: Enhancing implementation for personalized mental health care;Asian Journal of Psychiatry;2023-10
5. Natural Killer Cell Engagers (NKCEs): a new frontier in cancer immunotherapy;Frontiers in Immunology;2023-08-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3